BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12056820)

  • 1. Histone deacetylase inhibition results in decreased macrophage CD9 expression.
    Wang XQ; Alfaro ML; Evans GF; Zuckerman SH
    Biochem Biophys Res Commun; 2002 Jun; 294(3):660-6. PubMed ID: 12056820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
    Sng JC; Taniura H; Yoneda Y
    Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
    Han SB; Lee JK
    Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of macrophage CD9 expression by interferon-gamma.
    Wang XQ; Evans GF; Alfaro ML; Zuckerman SH
    Biochem Biophys Res Commun; 2002 Jan; 290(3):891-7. PubMed ID: 11798156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures.
    Vanhaecke T; Henkens T; Kass GE; Rogiers V
    Biochem Pharmacol; 2004 Aug; 68(4):753-60. PubMed ID: 15276083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice.
    Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2404-9. PubMed ID: 16141407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A.
    Kypreou KP; Sourlingas TG; Sekeri-Pataryas KE
    Exp Gerontol; 2004 Apr; 39(4):469-79. PubMed ID: 15050280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
    Wallace DM; Donovan M; Cotter TG
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells.
    Balasubramaniyan V; Boddeke E; Bakels R; Küst B; Kooistra S; Veneman A; Copray S
    Neuroscience; 2006 Dec; 143(4):939-51. PubMed ID: 17084985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
    Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
    Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.